Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Advanced Cancer
Interventions
DRUG

Meaning-Making intervention (MMi)

The MMi is a brief, individualized and manualized therapeutic approach based on post-trauma literature and designed to facilitate a search for meaning following a cancer diagnosis.

BEHAVIORAL

Empathic Visitor

They will provide the basic ingredients for fostering a good therapeutic relationship (i.e., trust, warmth, empathy, neutrality and authenticity) without further intervention or probing.

Trial Locations (2)

H3T 1E8

Jewish General Hospital, Montreal

H4A 3J1

McGill University Health Centre (MUHC), Montreal

All Listed Sponsors
collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

lead

Jewish General Hospital

OTHER

NCT02583932 - Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer | Biotech Hunter | Biotech Hunter